MIVADO.BIZ

Global process performance

News From Pharma Regulatory Boards
EMEA
FDA
TPD-HPFBI
TGA
PMDA
Other Links
GTHF
ICH
EPA
Watch and Intelligence News
Intellectual Property
Aerospace and Aeronautic
Agriculture and Foods
Bio-Pharmaceutics
Economy and Finance
Environment
Health and Medicine
Market and Business
Sciences and Technologies
Tools
Events
Documentation Centre
Survey
Submit an article
Advertising
   
   
Download Adobe Reader and Flash Player.
Get Adobe Reader

Get Adobe Flash Player

Performance & Innovation

Performance & Innovation !

 

 

COMPETITIVE AND BUSINESS INTELLIGENCE

EUROPE EMEA NOTICE DOCUMENTS


Draft ICH concept paper on pharmaco genomic (PG) biomarker qualification: Format and data standards

This concept paper supports a proposal for a new harmonized ICH guideline on important aspects for the qualification of PG biomarkers. Full document...

23 May 2008, Intelligent Agent
Concept paper on Minimum date requirements for an authorisation under exceptional circumstances for vaccines for emergency use against bluetongue

Bluetongue (BT) is a non-contagious, insect-transmitted disease that is caused by BT virus (BTV). It is principally a disease of sheep and other domestic and wild ruminant species. Full document...

19 Mar 2008, Intelligent Agent
Reflection Paper on the Implementation of Directive 2001/82/EC, as amended, in respect to the assessment of environmental risks of veterinary Medicinal Products

Directive 2001/82/EC, as amended by Directive 2004/28/EC [1], includes new provisions regarding the consideration of effects on the environment in the benefit/risk assessment of veterinary medicinal products and on the data requirements regarding such effects. Full document...

17 Mar 2008, Intelligent Agent
Reflection paper on consideration of adjuvants and preservatives under Council regulation (EEC) No 2377/90 laying down a community procedure for the establishment od Maximum Residue Limits of veterinary medicinal products in foodstuffs of animal origin

Adjuvants are excipients used in immunological products due to their capacity to increase and/or prolong the immune response to the active ingredient. This activity is a matter separate from their potential pharmacological activity. Full document...

19 Dec 2007, Intelligent Agent
Reflection Paper on pharmacogenomic samples, testing and data handling

This paper addressed reflections on some aspects surrounding pre-analytical, analytical and postanalytical steps surrounding PGx samples, testing and data handling, key for the scientific reliability of PGx data submitted for regulatory evaluation. Full document...

27 Nov 2007, Intelligent Agent
Comments received during the public consultation on Reflection paper on the risks associated with furocoumarins contained in preparations of Angelica archangelica L.
Comments received during the public consultation on Reflection paper on the risks associated with furocoumarins contained in preparations of Angelica archangelica L.  Full document...
20 Nov 2007, Intelligent Agent
Reflection Paper on the risks associated with furocoumarins contained in preparations of Angelica archangelica L.

This reflection paper focuses on coumarin-derivatives present in Angelica archangelica L., as these substances are the most relevant constituents for phototoxicity. In addition to these constituents, there are a large number of other compounds, which have been found e.g. in the essential oil. The safety of these constituents is not addressed in this paper. Full document...

15 Nov 2007, Intelligent Agent

<<< 1 2 3 4 5 6 7 8 9 >>>


MIVADO Business Centre
To Recieve Our Newsletter, click here
FREE FEEDBACK
How often do you visit this site?

WEB PARTNERS
Jurifax Contract Forms
Anywhere.ca - Canadian search engine and directory.
CFIB is Canada's largest association of SMEs representing over 100,000 firms.
toutMontreal.com
ispex.ca
ExactSeek - Relevant Search
 
 
 
 
 

 

 

Mivado GlobalPerformance, inc.

HomeAbout UsServicesPrivacy -  Contact Us

© 2007 Mivado GlobalPerformance, Inc. All rights reseved